Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 750
Single User License Price INR 53565
Corporate User License Price USD 2,250
Corporate User License Price INR 143
Site License Price USD 1,500
Site License Price INR 71
Request a Quote

Report Title

Quidel Corporation QDEL-Product Pipeline Analysis, 2016 Update

Quote Request for License Type
License Type Price  
Single User License USD 750
Site License USD 1,500
Enterprise Wide License USD 2,250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Quidel Corporation QDEL-Product Pipeline Analysis, 2016 Update


Quote Request for License Type
License Type Price  
Single User License USD 750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Quidel Corporation QDEL-Product Pipeline Analysis, 2016 Update

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Quidel Corporation QDEL-Product Pipeline Analysis, 2016 Update



Executive Summary

Summary

Quidel Corporation (Quidel) develops, manufactures and markets rapid diagnostic testing solutions that find applications in infectious diseases, gastrointestinal diseases and women's health. The company offers cell line products; diagnostic immunoassays including visually read rapid lateral flow tests, ELISAs and fluorescent immunoassays; and others. It offers diagnostic and research assays and reagents in oncology, bone health and inflammatory diseases. Quidel has its manufacturing and research and development facilities in California and Ohio. The company offers its products to physicians, hospitals, clinical laboratories, retail clinics and wellness screening centers. Quidel distributes its products through its direct sales force and also through a network of national and regional distributors. The company has a presence in the US and Germany through its offices and subsidiaries. Quidel is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Quidel Corporation

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Quidel Corporation Company Snapshot 7

Quidel Corporation Company Overview 7

Quidel Corporation Pipeline Products and Clinical Trials Overview 8

Quidel Corporation-Pipeline Analysis Overview 10

Business Description 10

Key Facts 11

Quidel Corporation-Major Products and Services 12

Quidel Corporation Pipeline Products by Development Stage 14

Quidel Corporation Pipeline Products Overview 17

AmpliVue-Meningitis 17

AmpliVue-Meningitis Product Overview 17

AmpliVue-MRSA Assay 18

AmpliVue-MRSA Assay Product Overview 18

AmpliVue-TB Assay 19

AmpliVue-TB Assay Product Overview 19

AmpliVue-VRE Assay 20

AmpliVue-VRE Assay Product Overview 20

Dual Block/Stim Assay 21

Dual Block/Stim Assay Product Overview 21

FIA C.difficile Assay 22

FIA C.difficile Assay Product Overview 22

HIV POC RT-PCR Testing Device 23

HIV POC RT-PCR Testing Device Product Overview 23

IsoAmp Assay-Chlamydia Trachomatis 24

IsoAmp Assay-Chlamydia Trachomatis Product Overview 24

IsoAmp Assay-Clostridium Difficile 25

IsoAmp Assay-Clostridium Difficile Product Overview 25

IsoAmp Assay-Dengue 26

IsoAmp Assay-Dengue Product Overview 26

IsoAmp Assay-Factor V Leiden 27

IsoAmp Assay-Factor V Leiden Product Overview 27

IsoAmp Assay-HIV 28

IsoAmp Assay-HIV Product Overview 28

IsoAmp Assay-HPV 29

IsoAmp Assay-HPV Product Overview 29

IsoAmp Assay-Malaria 30

IsoAmp Assay-Malaria Product Overview 30

IsoAmp Assay-Neisseria Gonorrhoeae 31

IsoAmp Assay-Neisseria Gonorrhoeae Product Overview 31

IsoAmp Assay-Tuberculosis 32

IsoAmp Assay-Tuberculosis Product Overview 32

IsoAmp HIV-1 Quantitative Assay 33

IsoAmp HIV-1 Quantitative Assay Product Overview 33

Open Box-CT/NG Assay 34

Open Box-CT/NG Assay Product Overview 34

Open Box-Entero/ Parechovirus Assay 35

Open Box-Entero/ Parechovirus Assay Product Overview 35

Open Box-Flu Subtyping Assay 36

Open Box-Flu Subtyping Assay Product Overview 36

Open Box-PIV/Rhino/Adeno Assay 37

Open Box-PIV/Rhino/Adeno Assay Product Overview 37

Open Box-Pneumonia Panel 38

Open Box-Pneumonia Panel Product Overview 38

Open Box-VRE Assay 39

Open Box-VRE Assay Product Overview 39

POC Molecular Diagnostic System 40

POC Molecular Diagnostic System Product Overview 40

Quantstudio DX-Respiratory Antigen Based Assay 41

Quantstudio DX-Respiratory Antigen Based Assay Product Overview 41

Sofia-Chlamydia 42

Sofia-Chlamydia Product Overview 42

Sofia-CT/NG Assay 43

Sofia-CT/NG Assay Product Overview 43

Sofia-fFN 44

Sofia-fFN Product Overview 44

Sofia-MRSA Assay 45

Sofia-MRSA Assay Product Overview 45

Sofia-PROM 46

Sofia-PROM Product Overview 46

Sofia-TSH 47

Sofia-TSH Product Overview 47

Sofia-Vitamin D 48

Sofia-Vitamin D Product Overview 48

Sofia hCG Assay-CLIA Waived 49

Sofia hCG Assay-CLIA Waived Product Overview 49

Sofia hCG Quant Assay 50

Sofia hCG Quant Assay Product Overview 50

Sofia S. Pneumoniae Fluorescent Immunoassay 51

Sofia S. Pneumoniae Fluorescent Immunoassay Product Overview 51

Quidel Corporation-Key Competitors 52

Quidel Corporation-Key Employees 53

Quidel Corporation-Key Employee Biographies 54

Quidel Corporation-Locations And Subsidiaries 55

Head Office 55

Other Locations & Subsidiaries 55

Recent Developments 56

Quidel Corporation, Recent Developments 56

Feb 17, 2016: Quidel Reports Fourth Quarter and Full Year 2015 Financial Results 56

Jan 25, 2016: Quidel Receives CE Mark for Its New Sofia Fluorescent Immunoassay for Diagnosis of Pneumococcal Pneumonia and Pneumococcal Meningitis 57

Jan 07, 2016: Quidel Announces Preliminary Revenue for Fourth Quarter 2015 57

Nov 17, 2015: Charlie Slacik Joins Quidel's Board of Directors 58

Nov 17, 2015: BÜHLMANN now distributes the Lyra Real-time PCR-Assays from Quidel 58

Oct 28, 2015: Quidel Reports Third Quarter 2015 Financial Results 58

Aug 19, 2015: Quidel Announces Changes to Board of Directors 59

Jul 22, 2015: Quidel Reports Second Quarter 2015 Financial Results 60

Jun 23, 2015: Quidel Receives FDA Clearance to market Solana Molecular System for Diagnosis of Group a Streptococcal Infections 61

Jun 23, 2015: Quidel Receives FDA Clearance for Solana Molecular Assay for Diagnosis of Group a Streptococcal Infections 62

Appendix 63

Methodology 63

About GlobalData 63

Contact Us 63

Disclaimer 63

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Quidel Corporation Pipeline Products by Equipment Type 9

Quidel Corporation Pipeline Products by Development Stage 14

List of Tables

Quidel Corporation Pipeline Products and Clinical Trials Overview 8

Quidel Corporation Pipeline Products by Equipment Type 8

Quidel Corporation Pipeline Products by Indication 9

Quidel Corporation, Key Facts 11

Quidel Corporation, Major Products and Services 12

Quidel Corporation Number of Pipeline Products by Development Stage 14

Quidel Corporation Pipeline Products Summary by Development Stage 15

AmpliVue-Meningitis-Product Status 17

AmpliVue-Meningitis-Product Description 17

AmpliVue-MRSA Assay-Product Status 18

AmpliVue-MRSA Assay-Product Description 18

AmpliVue-TB Assay-Product Status 19

AmpliVue-TB Assay-Product Description 19

AmpliVue-VRE Assay-Product Status 20

AmpliVue-VRE Assay-Product Description 20

Dual Block/Stim Assay-Product Status 21

Dual Block/Stim Assay-Product Description 21

FIA C.difficile Assay-Product Status 22

FIA C.difficile Assay-Product Description 22

HIV POC RT-PCR Testing Device-Product Status 23

HIV POC RT-PCR Testing Device-Product Description 23

IsoAmp Assay-Chlamydia Trachomatis-Product Status 24

IsoAmp Assay-Chlamydia Trachomatis-Product Description 24

IsoAmp Assay-Clostridium Difficile-Product Status 25

IsoAmp Assay-Clostridium Difficile-Product Description 25

IsoAmp Assay-Dengue-Product Status 26

IsoAmp Assay-Dengue-Product Description 26

IsoAmp Assay-Factor V Leiden-Product Status 27

IsoAmp Assay-Factor V Leiden-Product Description 27

IsoAmp Assay-HIV-Product Status 28

IsoAmp Assay-HIV-Product Description 28

IsoAmp Assay-HPV-Product Status 29

IsoAmp Assay-HPV-Product Description 29

IsoAmp Assay-Malaria-Product Status 30

IsoAmp Assay-Malaria-Product Description 30

IsoAmp Assay-Neisseria Gonorrhoeae-Product Status 31

IsoAmp Assay-Neisseria Gonorrhoeae-Product Description 31

IsoAmp Assay-Tuberculosis-Product Status 32

IsoAmp Assay-Tuberculosis-Product Description 32

IsoAmp HIV-1 Quantitative Assay-Product Status 33

IsoAmp HIV-1 Quantitative Assay-Product Description 33

Open Box-CT/NG Assay-Product Status 34

Open Box-CT/NG Assay-Product Description 34

Open Box-Entero/ Parechovirus Assay-Product Status 35

Open Box-Entero/ Parechovirus Assay-Product Description 35

Open Box-Flu Subtyping Assay-Product Status 36

Open Box-Flu Subtyping Assay-Product Description 36

Open Box-PIV/Rhino/Adeno Assay-Product Status 37

Open Box-PIV/Rhino/Adeno Assay-Product Description 37

Open Box-Pneumonia Panel-Product Status 38

Open Box-Pneumonia Panel-Product Description 38

Open Box-VRE Assay-Product Status 39

Open Box-VRE Assay-Product Description 39

POC Molecular Diagnostic System-Product Status 40

POC Molecular Diagnostic System-Product Description 40

Quantstudio DX-Respiratory Antigen Based Assay-Product Status 41

Quantstudio DX-Respiratory Antigen Based Assay-Product Description 41

Sofia-Chlamydia-Product Status 42

Sofia-Chlamydia-Product Description 42

Sofia-CT/NG Assay-Product Status 43

Sofia-CT/NG Assay-Product Description 43

Sofia-fFN-Product Status 44

Sofia-fFN-Product Description 44

Sofia-MRSA Assay-Product Status 45

Sofia-MRSA Assay-Product Description 45

Sofia-PROM-Product Status 46

Sofia-PROM-Product Description 46

Sofia-TSH-Product Status 47

Sofia-TSH-Product Description 47

Sofia-Vitamin D-Product Status 48

Sofia-Vitamin D-Product Description 48

Sofia hCG Assay-CLIA Waived-Product Status 49

Sofia hCG Assay-CLIA Waived-Product Description 49

Sofia hCG Quant Assay-Product Status 50

Sofia hCG Quant Assay-Product Description 50

Sofia S. Pneumoniae Fluorescent Immunoassay-Product Status 51

Sofia S. Pneumoniae Fluorescent Immunoassay-Product Description 51

Quidel Corporation, Key Employees 53

Quidel Corporation, Key Employee Biographies 54

Quidel Corporation, Other Locations 55

Quidel Corporation, Subsidiaries 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Cepheid

Chemicon International, Inc.

Becton, Dickinson and Company

Sekisui Medical Co., Ltd.

Meridian Bioscience, Inc.

Beckman Coulter, Inc.

Alere Inc.

Fisher Scientific Corporation

Quidel Corporation, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand